Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays

Hepatology

Volumn 33, Issue 4, 2001, Pages 832-840

  Shirota, Y ^a   Kaneko, S ^a   Honda, M ^a   Kawai, H F ^a   Kobayashi, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CELL DIFFERENTIATION; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DNA HYBRIDIZATION; DNA MICROARRAY; FLUORESCENCE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

EID: 0035088412     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.23003     Document Type: Article

References (59)

1. Expression of transforming growth factor alpha in human hepatocellular carcinoma
2. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma
3. Protein expression of p53, p21WAF1, and Rb as prognostic indicators in patients with surgically treated hepatocellular carcinoma
4. Expression profiling in cancer using cDNA microarrays
5. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray
6. Identification of genes differentially over-expressed in lung squamous cell carcinoma using combination of cDNA subtraction and microarray analysis
7. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis
8. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma
9. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
10. Classification of chronic hepatitis: Diagnosis, grading and staging
11. Use of a cDNA microarray to analyse gene expression patterns in human cancer
12. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
13. Cell cycle regulation of hepatitis C virus internal ribosomal entry site-directed translation
14. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
15. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization
16. Chromosomal aberrations in hepatocellular carcinomas: Relationship with pathological features
17. Cytoplasmic dynein (ddlc1) mutations cause morphogenetic defects and apoptotic cell death in Drosophila melanogaster
18. I kappaB alpha physically interacts with a cytoskeleton-associated protein through its signal response domain
19. Rho proteins induce metastatic properties in vivo
20. Identification of a new enhancer in the promoter region of human TR3 orphan receptor gene. A member of steroid receptor superfamily
21. Thymic lymphomas are resistant to Nur77-mediated apoptosis
22. Molecular cloning of complementary DNA for a novel human hepatoma- derived growth factor. Its homology with high mobility group-1 protein
23. Stage-specific gene expression during hepatocarcinogenesis in the rat
24. The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: Immunohistochemical analysis
25. NM23-H1 and NM23-H2 messenger RNA abundance in human hepatocellular carcinoma
26. Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinoma
27. Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model
28. Expression and function of CXC and CC chemokines in human malignant liver tumors: A role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma
29. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12
30. Interleukin-8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C
31. Reduced expression of the CXC chemokine hIRH/SDF-1alpha mRNA in hepatoma and digestive tract cancer
32. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis
33. The role of CXC chemokines in the regulation of angiogenesis in non-small cell lung cancer
34. Gro-beta, a -C-X-C-chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice
35. Elevated levels of transforming growth factor beta messenger RNA and its polypeptide in human hepatocellular carcinoma
36. Plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma. Comparison with chronic liver diseases
37. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma
38. Expression of insulin-like growth factor II (IGF-II) in human hepatocellular carcinomas: An immunohistochemical study
39. Allelic imbalance of insulin-like growth factor II gene expression in cancerous and precancerous lesions of the liver
40. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma
41. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
42. Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma
43. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma
44. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma
45. Deletion of Dad1 in mice induces an apoptosis-associated embryonic death
46. Plakoglobin regulates the expression of the anti-apoptotic protein BCL- 2
47. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas
48. Insulin-like growth factor 2 and insulin-like growth factor binding protein 2 expression in hepatoblastoma
49. Core-binding factor: A central player in hematopoiesis and leukemia
50. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle
51. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: Interference with transcriptional activation by NFI/CTF in a cell-type specific manner
52. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1
53. Developmental regulation of Zbul, a DNA-binding member of the SWI2/SNF2 family
54. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression
55. Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle
56. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2
57. The role of RhoA in tissue polarity and Frizzled signalling
58. Smad2 overexpression enhances Smad4 gene expression and suppresses CBFA1 gene expression in osteoblastic osteosarcoma ROS17/ 2.8 cells and primary rat calvaria cells
59. Cyclin-dependent kinase inhibitor p21 modulates the DNA primer-template recognition complex